Samantha Cassetty, MS, RD, is a registered dietitian nutritionist and co-author of the book Sugar Shock. Highlights ...

Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the best NASDAQ growth stocks to buy for the next 3 years.

A new study found that Ozempic's main ingredient may treat people with type 1 diabetes, control blood sugar, and lose weight.

Type 2 diabetes remission and weight loss rates are significantly higher among adults who replace diet beverages with water.

Sana Biotechnology, Inc. (NASDAQ:SANA) ranks among the best CRISPR stocks to buy. On June 24, Citizens JMP reaffirmed its $5 ...

In summary, foot care is a vital part of managing type 2 diabetes. Simple steps like daily foot checks, gentle washing, ...

A study found that the newer generation of much more effective diabetes medications are reaching only a fraction of the ...

The highly competitive, $100,000 award supports mission-driven graduate students working toward a professional or advanced ...

The use of a smart speaker with preprogrammed diabetes care features may help older adults manage their diabetes and improve ...

After a one-year follow-up, 10 of 12 patients given the islet cell therapy zimislecel no longer required insulin. Vertex ...

The annual meeting of the American Diabetes Association was held this year from June 20 to 23 in Chicago, drawing more than ...

The diabetes conference featured a debate about over-the-counter glucose monitors and updates on upcoming devices, including ...